Office of the Secretary; Notice of Meeting, 71516-71517 [2016-24954]
Download as PDF
jstallworth on DSK7TPTVN1PROD with NOTICES
71516
Federal Register / Vol. 81, No. 200 / Monday, October 17, 2016 / Notices
and Training Review Branch, Division of
Extramural Activities, National Cancer
Institute, 9609 Medical Center Drive, Room
7W624, Rockville, MD 20892–9750, 240–
276–6464, meekert@mail.nih.gov.
Name of Committee: National Cancer
Institute Special Emphasis Panel; NCI
Omnibus SEP 2.
Date: November 14–15, 2016.
Time: 7:30 a.m. to 3:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Hyatt Regency Bethesda, One
Bethesda Metro Center, 7400 Wisconsin
Avenue, Bethesda, MD 20814.
Contact Person: Denise L. Stredrick, Ph.D.,
Scientific Review Officer, Special Review
Branch, Division of Extramural Activities,
National Cancer Institute, 9609 Medical
Center Drive, Room 7W640, Rockville, MD
20892–9750, 240–276–5053, stredrid@
mail.nih.gov.
Name of Committee: National Cancer
Institute Special Emphasis Panel; NCI Lasker
Clinical Research Scholars Program.
Date: November 15, 2016.
Time: 10:00 a.m. to 11:00 a.m.
Agenda: To review and evaluate grant
applications.
Place: National Cancer Institute Shady
Grove, 9609 Medical Center Drive, Room
7W126, Rockville, MD 20850, (Telephone
Conference Call).
Contact Person: Caron A. Lyman, Ph.D.,
Chief, Scientific Review Officer, Research
Programs Review Branch, Division of
Extramural Activities, National Cancer
Institute, 9609 Medical Center Drive, Room
7W126, Rockville, MD 20892–9750, 240–
276–6348, lymanc@mail.nih.gov.
Name of Committee: National Cancer
Institute Special Emphasis Panel; Assay
Validation for High Quality Markers.
Date: November 18, 2016.
Time: 3:00 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Cancer Institute Shady
Grove, 9609 Medical Center Drive, Room
3W030, Rockville, MD 20850, (Telephone
Conference Call).
Contact Person: Jeffrey E. DeClue, Ph.D.,
Scientific Review Officer, Research
Technology and Contract Review Branch,
Division of Extramural Activities, National
Cancer Institute, 9609 Medical Center Drive,
Room 7W114, Rockville, MD 20892–9750,
240–276–6371, decluej@mail.nih.gov.
Name of Committee: National Cancer
Institute Initial Review Group; Subcommittee
A—Cancer Centers.
Date: December 1, 2016.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Hyatt Regency Bethesda, One
Bethesda Metro Center, 7400 Wisconsin
Avenue, Bethesda, MD 20814.
Contact Person: Shamala K. Srinivas,
Ph.D., Associate Director, Office of Referral,
Review, and Program Coordination, Division
of Extramural Activities, National Cancer
Institute, 9609 Medical Center Drive, Room
7W530, Rockville, MD 20892–9750, 240–
276–6442 ss537t@nih.gov.
VerDate Sep<11>2014
14:22 Oct 14, 2016
Jkt 241001
Name of Committee: National Cancer
Institute Special Emphasis Panel; Informatics
Technology.
Date: December 15–16, 2016.
Time: 8:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Bethesda North Marriott Hotel &
Conference Center, 5701 Marinelli Road,
Bethesda, MD 20852.
Contact Person: Nadeem Khan, Ph.D.,
Scientific Review Officer, Research
Technology and Contract Review Branch,
Division of Extramural Activities, National
Cancer Institute, 9609 Medical Center Drive,
Room 7W260, Rockville, MD 20892–9750,
240–276–5856, nadeem.khan@nih.gov.
Name of Committee: National Cancer
Institute Special Emphasis Panel; NCI
Program Project II (P01).
Date: January 31–February 1, 2017.
Time: 8:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Hilton Washington/Rockville, 1750
Rockville Pike, Rockville, MD 20852.
Contact Person: Sanita Bharti, Ph.D.,
Scientific Review Officer, Research Program
Review Branch, Division of Extramural
Activities, National Cancer Institute, 9609
Medical Center Drive, Room 7W618,
Rockville, MD 20892–9750, 240–276–5909,
sanitab@mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.392, Cancer Construction;
93.393, Cancer Cause and Prevention
Research; 93.394, Cancer Detection and
Diagnosis Research; 93.395, Cancer
Treatment Research; 93.396, Cancer Biology
Research; 93.397, Cancer Centers Support;
93.398, Cancer Research Manpower; 93.399,
Cancer Control, National Institutes of Health,
HHS)
Dated: October 11, 2016.
Melanie J. Gray,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2016–24950 Filed 10–14–16; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute on Aging; Notice of
Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
PO 00000
Frm 00042
Fmt 4703
Sfmt 4703
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute on
Aging Special Emphasis Panel; DIAN.
Date: November 7, 2016.
Time: 11:00 a.m. to 1:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institute on Aging,
Gateway Building, 2W200, 7201 Wisconsin
Avenue, Bethesda, MD 20892, (Telephone
Conference Call).
Contact Person: Jeannette L. Johnson,
Ph.D., National Institutes on Aging, National
Institutes of Health, 7201 Wisconsin Avenue,
Suite 2W200, Bethesda, MD 20892, 301–402–
7705, johnsonj9@nia.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.866, Aging Research,
National Institutes of Health, HHS)
Dated: October 11, 2016.
Melanie J. Gray,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2016–24951 Filed 10–14–16; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Office of the Secretary; Notice of
Meeting
Pursuant to section 10(a) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of a meeting of the
Muscular Dystrophy Coordinating
Committee (MDCC).
The meeting will be open to the
public, with attendance limited to space
available. Individuals who plan to
attend and need special assistance, such
as sign language interpretation or other
reasonable accommodations, should
notify the Contact Person listed below
in advance of the meeting.
Name of Committee: Muscular Dystrophy
Coordinating Committee.
Type of meeting: Open Meeting.
Date: November 29, 2016.
Time: 8:30 a.m. to 4:30 p.m. *Eastern
Time*—Approximate end time.
Agenda: The purpose of this meeting is to
bring together committee members,
representing government agencies, patient
advocacy groups, other voluntary health
organizations, and patients and their families
to update one another on progress relevant to
the Action Plan for the Muscular Dystrophies
and to coordinate activities and discuss gaps
and opportunities leading to better
understanding of the muscular dystrophies,
advances in treatments, and improvements in
patients’ and their families’ lives. Prior to the
meeting, an agenda will be posted to the
MDCC meeting registration Web site: https://
E:\FR\FM\17OCN1.SGM
17OCN1
Federal Register / Vol. 81, No. 200 / Monday, October 17, 2016 / Notices
meetings.ninds.nih.gov/meetings/
MDCC29November2016/.
Registration: To register, please go to:
https://meetings.ninds.nih.gov/meetings/
MDCC29November2016/.
Webcast Live: For those not able to attend
in person, this meeting will be webcast at:
https://videocast.nih.gov/.
Place: Neuroscience Center, Conference
Room C/D, 6001 Executive Boulevard,
Rockville, Maryland 20852.
Contact Person: Glen H. Nuckolls, Ph.D.,
Executive Secretary, Muscular Dystrophy
Coordinating Committee, National Institute
of Neurological Disorders and Stroke, NIH,
6001 Executive Boulevard, NSC 2203,
Bethesda, MD 20892, (301) 496–5745,
glen.nuckolls@ninds.nih.gov.
Any member of the public interested in
presenting oral comments to the committee
may notify the Contact Person listed on this
notice at least 10 days in advance of the
meeting. Interested individuals and
representatives of organizations may submit
a letter of intent, a brief description of the
organization represented, and a short
description of the oral presentation. Only one
representative of an organization may be
allowed to present oral comments and if
accepted by the committee, presentations
may be limited to five minutes. Both printed
and electronic copies are requested for the
record. In addition, any interested person
may file written comments with the
committee by forwarding their statement to
the Contact Person listed on this notice. The
statement should include the name, address,
telephone number and when applicable, the
business or professional affiliation of the
interested person.
All visitors must go through a security
check at the building entrance to receive a
visitor’s badge. A government issued photo
ID is required. Further information can be
found at the registration Web site: https://
meetings.ninds.nih.gov/meetings/
MDCC29November2016/.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.853, Clinical Research
Related to Neurological Disorders; 93.854,
Biological Basis Research in the
Neurosciences, National Institutes of Health,
HHS)
Dated: October 11, 2016.
Sylvia L. Neal,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2016–24954 Filed 10–14–16; 8:45 am]
BILLING CODE 4140–01–P
jstallworth on DSK7TPTVN1PROD with NOTICES
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of
Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
VerDate Sep<11>2014
14:22 Oct 14, 2016
Jkt 241001
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Center for Scientific
Review Special Emphasis Panel, Member
Conflict: AIDS-Related Dissemination and
Implementation Research in Health.
Date: November 9, 2016.
Time: 12:00 p.m. to 2:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892,
(Telephone Conference Call).
Contact Person: Jessica Bellinger, Ph.D.,
Scientific Review Administrator, Center for
Scientific of Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3158,
Bethesda, MD 20892, bellingerjd@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel, PAR–16–
116: Bioengineering Research Partnerships.
Date: November 10, 2016.
Time: 11:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892,
(Virtual Meeting).
Contact Person: Mehrdad Mohseni, MD,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5211,
MSC 7854, Bethesda, MD 20892, 301–435–
0484, mohsenim@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel, Lasker
Clinical Research Scholars Program (S12).
Date: November 10, 2016.
Time: 12:00 p.m. to 2:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892,
(Telephone Conference Call).
Contact Person: Sara Ahlgren, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, RM 4136,
Bethesda, MD 20892, 301–435–0904,
sara.ahlgren@nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel, Small
Business: Psycho/Neuropathology, Lifespan
Development, and STEM Education.
Date: November 14–15, 2016.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To provide concept review of
proposed grant applications.
Place: Residence Inn Alexandria Old
Town/Duke Street, 1456 Duke Street,
Alexandria, VA 22314.
Contact Person: John H Newman, Ph.D.,
Scientific Review Officer, Center for
PO 00000
Frm 00043
Fmt 4703
Sfmt 4703
71517
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3222,
MSC 7808, Bethesda, MD 20892, (301) 435–
0628, newmanjh@csr.nih.gov.
Name of Committee: AIDS and Related
Research Integrated Review Group,
Behavioral and Social Consequences of HIV/
AIDS Study Section.
Date: November 15–16, 2016.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: DoubleTree Suites by Hilton Hotel
Tampa Bay, 3050 N. Rocky Point Dr. West,
Tampa, FL 33607580.
Contact Person: Mark P Rubert, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5218,
MSC 7852, Bethesda, MD 20892, 301–806–
6596, rubertm@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel,
Fellowships: Cell Biology, Developmental
Biology, and Bioengineering.
Date: November 15–16, 2016.
Time: 10:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892.
Contact Person: Alexander Gubin, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4196,
MSC 7812, Bethesda, MD 20892, 301–435–
2902, gubina@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel, Shared
Instrumentation: Genes Genomes Genetics.
Date: November 15, 2016.
Time: 11:00 a.m. to 4:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892,
(Telephone Conference Call).
Contact Person: Methode Bacanamwo,
Ph.D., Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Bethesda, MD
20892, 301–827–7088,
methode.bacanamwo@nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel, PAR–13–
231: Phenotyping Embryonic Lethal
Knockout Mice.
Date: November 15, 2016.
Time: 1:00 p.m. to 4:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892,
(Telephone Conference Call).
Contact Person: John Burch, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institute of
Health, 6701 Rockledge Drive, Room 3213,
MSC 7808, Bethesda, MD 20892, 301–408–
9519, burchjb@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel, Member
Conflict: DNA Damage and Tumorigenesis.
Date: November 15, 2016.
Time: 1:00 p.m. to 5:00 p.m.
E:\FR\FM\17OCN1.SGM
17OCN1
Agencies
[Federal Register Volume 81, Number 200 (Monday, October 17, 2016)]
[Notices]
[Pages 71516-71517]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2016-24954]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Office of the Secretary; Notice of Meeting
Pursuant to section 10(a) of the Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is hereby given of a meeting of the
Muscular Dystrophy Coordinating Committee (MDCC).
The meeting will be open to the public, with attendance limited to
space available. Individuals who plan to attend and need special
assistance, such as sign language interpretation or other reasonable
accommodations, should notify the Contact Person listed below in
advance of the meeting.
Name of Committee: Muscular Dystrophy Coordinating Committee.
Type of meeting: Open Meeting.
Date: November 29, 2016.
Time: 8:30 a.m. to 4:30 p.m. *Eastern Time*--Approximate end
time.
Agenda: The purpose of this meeting is to bring together
committee members, representing government agencies, patient
advocacy groups, other voluntary health organizations, and patients
and their families to update one another on progress relevant to the
Action Plan for the Muscular Dystrophies and to coordinate
activities and discuss gaps and opportunities leading to better
understanding of the muscular dystrophies, advances in treatments,
and improvements in patients' and their families' lives. Prior to
the meeting, an agenda will be posted to the MDCC meeting
registration Web site: https://
[[Page 71517]]
meetings.ninds.nih.gov/meetings/MDCC29November2016/.
Registration: To register, please go to: https://meetings.ninds.nih.gov/meetings/MDCC29November2016/.
Webcast Live: For those not able to attend in person, this
meeting will be webcast at: https://videocast.nih.gov/.
Place: Neuroscience Center, Conference Room C/D, 6001 Executive
Boulevard, Rockville, Maryland 20852.
Contact Person: Glen H. Nuckolls, Ph.D., Executive Secretary,
Muscular Dystrophy Coordinating Committee, National Institute of
Neurological Disorders and Stroke, NIH, 6001 Executive Boulevard,
NSC 2203, Bethesda, MD 20892, (301) 496-5745,
glen.nuckolls@ninds.nih.gov.
Any member of the public interested in presenting oral comments
to the committee may notify the Contact Person listed on this notice
at least 10 days in advance of the meeting. Interested individuals
and representatives of organizations may submit a letter of intent,
a brief description of the organization represented, and a short
description of the oral presentation. Only one representative of an
organization may be allowed to present oral comments and if accepted
by the committee, presentations may be limited to five minutes. Both
printed and electronic copies are requested for the record. In
addition, any interested person may file written comments with the
committee by forwarding their statement to the Contact Person listed
on this notice. The statement should include the name, address,
telephone number and when applicable, the business or professional
affiliation of the interested person.
All visitors must go through a security check at the building
entrance to receive a visitor's badge. A government issued photo ID
is required. Further information can be found at the registration
Web site: https://meetings.ninds.nih.gov/meetings/MDCC29November2016/.
(Catalogue of Federal Domestic Assistance Program Nos. 93.853,
Clinical Research Related to Neurological Disorders; 93.854,
Biological Basis Research in the Neurosciences, National Institutes
of Health, HHS)
Dated: October 11, 2016.
Sylvia L. Neal,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2016-24954 Filed 10-14-16; 8:45 am]
BILLING CODE 4140-01-P